Kartos Therapeutics
Home | Kartos Theraputics
Redwood City, United States · $90.0M raised
- Headquarters
- Redwood City, California
- Employees
- 11–50
- Business Model
- B2B
- Website
- kartosthera.com
- Total Funding
- $90.0M
- Last Round
- $90.0M Series BJan 2020
- Rounds
- 1
About
Clinical-stage biopharmaceutical company developing navtemadlin, an investigational MDM2 inhibitor for oncology.
Summary
Kartos Therapeutics is a Biotech company based in Redwood City, United States. It has raised $90.0M in total across 1 round, most recently a $90.0M Series B round in Jan 2020. Investors include SR One, Amgen and OrbiMed.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2020
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...